Avvaa Appoints New Officers

Monday, 17 May 2010 09:57 AM

Vernon, BC May 17, 2010 — avVaa World Health Care Products Inc. (“avVaa” or the “Company”) (Pink Sheets:  AVVH) wishes to announce that its Board of Directors has made the following appointments:

 

·         Mr. Lance Loose - Chief Executive Officer (CEO);

·         Mr. Roland Busch - President and Chief Operations Officer (COO); and

·         Mrs. Ruth Brennan - Chief Financial Officer (CFO)

 

Mr. Loose has 19 years experience in international sales & marketing with a prominent industry leader, Tolko Industries Inc., based in Vernon, BC.  His experience ranges from production to market research and sales.  He has been responsible for the introduction of new products into existing markets and the introduction of existing products into new markets, including China.  Mr. Loose will initially be working with avVaa on a part-time basis.

 

Roland (“RJ”) Busch has diversified experience in the hospitality and management industry where he managed several supply warehouses, restaurants and hotels.  Mr. Busch’s background includes strategic management, customer service, sales, marketing and fiscal responsibilities.  His successful team leadership abilities derive from his 21 years service in the Canadian Military, his emphasis on strong attention to detail, and his strategic planning and execution.  Mr. Busch believes in a strong commitment to professional customer service and operations.  He will be joining avVaa on a full-time basis.

 

Mrs. Brennan states:  “As the new direction of avVaa’s future is to break into the market place and become a household name, I am very pleased to bring together a team of sales and marketing specialists that will have one focus:  SALES!”  

 

About avVaa World Health Care Products avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers.  avVaa's patented European skin care formulas are scientifically registered, FDA‐Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne.  avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally.  The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada.  For more information, visit: www.avvaa.com or contact Merle Goertz, Public Relations, at 1‐866‐864‐6598 Ext. 705.

 

Ruth Brennan, Director

avVaa World Health Care Products Inc

P: 1-866-864-6598

www.avvaa.com

Pink Sheets: AVVH



Safe Harbor:  This news release contains statements which may constitute "forward‐looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward‐looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward‐looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward‐statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before‐mentioned transactions. The Company undertakes no obligation to update or revise forward‐looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.